Stock Spotlights Archives - Page 10 of 19

WednesdayDec 14, 2022 2:03 pm

TinyGemsBreaks – Cepton Inc. (NASDAQ: CPTN) Well Funded to Scale Lidar Technology for Mass Deployment

Cepton (NASDAQ: CPTN), a Silicon Valley innovator and leader in high-performance lidar solutions, recently entered into a binding agreement for a $100 million investment from Koito Manufacturing Co., Ltd., its long-term automotive tier 1 partner and current shareholder. Cepton “intends to use this investment – Koito’s third since 2020 – to fund the company’s next growth stage as it looks to execute its vision to scale lidar technology for mass deployment… Cepton and Koito have had an established history of collaboration, including one that has been crowned with notable success, such as a significant ADAS lidar series production award on…

MondayDec 12, 2022 12:45 pm

TinyGemsBreaks – Freight Technologies Inc.’s (NASDAQ: FRGT) B2B Marketplace Offers Real-Time Portal to Connect Shippers, Carriers

Freight Technologies (NASDAQ: FRGT) (“Fr8Tech”), a technology company developing solutions to optimize and automate the supply chain process, provides a platform for B2B cross-border shipping across the USMCA (U.S.-Mexico-Canada) region. “The company’s mission is to revolutionize cross-border shipping by providing carriers with increased growth opportunities and shippers with flexibility, visibility and simplicity for the once-complex process of international over-the-road shipping,” a recent article reads. “Fr8Tech is leveraging its technology to help improve its customers’ operational efficiency and security while reducing its carbon footprint by optimizing empty miles and reducing paper consumption. Fr8App is a cloud-based marketplace that combines all aspects…

ThursdayDec 08, 2022 1:46 pm

TinyGemsBreaks – Lexaria Bioscience Corp.’s (NASDAQ: LEXX) Latest DehydraTECH-CBD Study May Be 1st to Evidence Sustained Drop in Blood Pressure

Lexaria Bioscience Corp. (NASDAQ: LEXX), a global leader in enhancing the speed and efficiency of orally delivered fat-soluble active molecules and drugs, has, since inception, been committed to addressing severe unmet patient needs. Hypertension has been one of its main focus areas. “Lexaria continues to move forward, most recently with the success in its latest human clinical study, HYPER-H21-4. The study may be the first to evidence a sustained drop in blood pressure in normally active patients following multiple weeks of oral cannabidiol (‘CBD’) therapy using the company’s patented DehydraTECH(TM) technology,” reads a recent article. “Since Lexaria began developing DehydraTECH…

FridayDec 02, 2022 1:48 pm

TinyGemsBreaks – Cepton Inc. (NASDAQ: CPTN) Taking Lidar Mainstream, Enabling World’s Leading Automotive Companies to Integrate at Scale

Cepton (NASDAQ: CPTN) is a Silicon Valley innovator of lidar-based solutions for autonomous vehicle (“AV”) and advanced driver assistance system (“ADAS”) sectors. “Cepton leads the way in enabling the world’s leading automotive companies to integrate lidar at scale and transition to an increasingly adaptive, safety-centric future. Safety is at the forefront of ADAS/AV technology concerns, and the industry’s success hinges on the availability of perception solutions that accurately identify objects under various conditions… Dr. Jun Pei, CEO and co-founder of Cepton, believes lidar brings unparalleled vehicle perception by ‘seeing’ things in 3D instead of the standard 2D view produced by…

WednesdayNov 23, 2022 3:26 pm

TinyGemsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Seeking to Solve Unmet Need for GBM Treatment

CNS Pharmaceuticals (NASDAQ: CNSP) is an oncology drug development company specializing in developing anti-cancer drugs for the treatment of primary and metastatic brain and central nervous system cancer. “The first half of fiscal 2022 saw the company make a number of clinical and operational advancements in its pursuit of treatment for glioblastoma multiforme (‘GBM’), according to CNS Pharmaceuticals CEO John Climaco. The company’s focus and priorities, Climaco emphasized, are firmly anchored in the advancement of its clinical development for its drug candidate Berubicin with the aim of bringing meaningful treatment to GBM patients. And as he separately told attendees at…

WednesdayNov 23, 2022 2:17 pm

TinyGemsBreaks – Cepton Inc. (NASDAQ: CPTN) Bridging Gap Between Lidar Concept and Deployment with NVIDIA DRIVE Sim(TM)

Cepton (NASDAQ: CPTN) recently teamed up with NVIDIA to add its lidars into NVIDIA DRIVE Sim(TM) – an end-to-end simulation platform for large-scale, accurate multi-sensor simulation that supports autonomous driving development and validation from concept to deployment. “With this collaboration, Cepton seeks to accelerate the development of lidar solutions for assisted and autonomous driving for global consumers. NVIDIA DRIVE Sim simulations enable automakers and developers to work with Cepton’s lidar models in a virtual environment to identify suitable Cepton lidar sensors for specific application needs and integrate them with other sensor technologies, such as camera and radar. They can prototype…

FridayNov 18, 2022 12:29 pm

TinyGemsBreaks – Lexaria Bioscience Corp.’s (NASDAQ: LEXX) Potential Hypertension Treatment Poised to Provide Reprieve to Millions of Patients

Lexaria Bioscience Corp. (NASDAQ: LEXX) is developing a potential hypertension treatment with little to no side effects. “The treatment is created by processing cannabidiol (‘CBD’) using the company’s patented DehydraTECH(TM) drug delivery technology, which has been shown to substantially increase the bioavailability of active pharmaceutical ingredients (‘APIs’). In human studies, Lexaria has shown that DehydraTECH-CBD not only increases the amount of CBD in the blood by as much as 317% but also reduces blood pressure and arterial stiffness,” a recent article reads. “Lexaria hopes to prove, through registered clinical trials, that its DehydraTECH-CBD formulation has an acceptable safety and tolerability…

TuesdayNov 15, 2022 11:00 am

TinyGemsBreaks – Freight Technologies Inc. (NASDAQ: FRGT) Focused on Improving Commerce Between US and Mexico

Freight Technologies (NASDAQ: FRGT) (“Fr8Tech”) is an over-the-road (“OTR”) shipping technology investor based in Houston, Texas. The company is focused on further improving commerce between the United States and Mexico by developing solutions that make the commercial truck industry’s supply chain processes more efficient. “Fr8Tech uses automation and transparent, real-time metrics that are communicated between shippers and qualified carriers – concentrating on cross-border as well as intra-national shipping within North America’s NAFTA trade area. The company’s flagship AI-powered Fr8App B2B marketplace can be of particular significance to smaller carriers working to meet Mexico’s tight CFDI 4.0 freight compliance reporting standards…

MondayNov 07, 2022 1:49 pm

TinyGemsBreaks – CNS Pharmaceuticals Inc.’s (NASDAQ: CNSP) Targeted ‘Finish Line Is Within Sight’ as It Pursues Potential GBM Treatment

CNS Pharmaceuticals (NASDAQ: CNSP) has been developing drug candidates for treating primary and metastatic brain and central nervous system cancer. “Berubicin, the company’s lead drug candidate, is a novel anthracycline in an ongoing international trail in glioblastoma (“GBM”) treatment. The interim analysis data from this potentially pivotal trial is expected in mid-2023… Berubicin was the first [anthracycline] to provide scientific data which appears to demonstrate its ability to cross the blood-brain barrier and was designed with a molecular target of topoisomerase II enzymes responsible for cleaving and recombing double-stranded DNA during cellular replication,” a recent article explains. “Since the beginning…

FridayNov 04, 2022 2:00 pm

TinyGemsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Increasing Access to Safe, Legal CBD and THC to Global Consumers

Flora Growth Corp. (NASDAQ: FLGC) is a cannabis cultivator, brand manufacturer and global distributor. “The Canadian company with a productive base of operations in Colombia’s fertile greenbelt is licensed to cultivate cannabis on a 100-hectare (about 247-acre) farming facility and then deliver its product to its GMP-certified processing facility in the nation’s capital, where beauty, phytotherapeutic and nutraceutical products are prepared for market…. Flora’s brand division is focused on developing plant-based consumer products, such as cannabinoid-infused juices, gummies, topicals, inhalables, and skin care. But the company also prioritizes the manufacture of ‘cannabinoid-derived medical formulations that can be sold domestically and…

Spotlighting undiscovered companies with enormous upside potential.

Contact us: (512) 354-7000

Breaks Categories: Stock Spotlights